Patent: 9,931,458
✉ Email this page to a colleague
Summary for Patent: 9,931,458
Title: | Multi chamber flexible bag and methods of using same |
Abstract: | A method of preparing a pharmaceutical product in a single multiple chamber flexible bag. A pharmaceutical product is introduced in a liquid state into a first chamber of the flexible bag through a first port. The pharmaceutical product is lyophilized within the first chamber of the flexible bag to provide a lyophilized pharmaceutical product. The flexible bag has a second chamber and the first chamber and the second chamber are separated by a breakable seal. The second chamber further includes a reconstituting solution for reconstituting the lyophilized pharmaceutical product in the first chamber. A user may apply pressure to the flexible bag to break the seal and mix the lyophilized pharmaceutical product and the reconstituting solution to order to administer the pharmaceutical product to a patient. |
Inventor(s): | Di Naro; Antonio Francesco (Morcote, CH) |
Assignee: | ADIENNE PHARMA & BIOTECH SA (Lugano, CH) |
Application Number: | 15/667,785 |
Patent Claims: | see list of patent claims |
Details for Patent 9,931,458
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2037-05-31 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2037-05-31 |
Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 08/19/2011 | ⤷ Try a Trial | 2037-05-31 |
Genentech, Inc. | HERCEPTIN HYLECTA | trastuzumab and hyaluronidase-oysk | Injection | 761106 | 02/28/2019 | ⤷ Try a Trial | 2037-05-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |